Persons deficient in GTAs have been shown to have an increased risk of colorectal cancer and pancreatic cancer and other inflammatory diseases. GTAs are ultra-long chain fatty acids that are made by gut microbes and absorbed into the blood supply. They have anti-inflammatory and anti-cancer properties. Over 90% of colorectal and pancreatic cancer cases are detected in persons with GTA levels below the 25th percentile.
To access the FREE seminars with full presentations and videos please visit Dr. Goodenowe’s resource site here. This is the article for seminar B103, Blood Tests and Biomarkers (Series B).
Dr. Goodenowe’s laboratory was the first to discover and characterize these very important biochemicals.
The ProdromeScan test measures 21 different GTA species in your blood. The levels of these GTAs are combined to provide an overall assessment of your GTA system. Of the 21 GTAs, 15 are most strongly linked to increased risk of colorectal cancer. The total overall value of these 15 GTAs is reported. Of the 21 GTAs, 6 are most strongly linked to increased risk of pancreatic cancer. The total overall value of these 6 GTAs is reported.
Dr. Goodenowe explains the relevant research and literature regarding blood GTA levels in seminar B103 – Gastrointestinal Tract Acids.